| Literature DB >> 22081362 |
Anthanasia Anagostou1, Lance A Liotta.
Abstract
Molecular profiling, which is the application of molecular diagnostics technology to tissue and blood -specimens, is an integral element in the new era of molecular medicine and individualized therapy. Molecular diagnostics is a fertile ground for small business development because it can generate products that meet immediate demands in the health-care sector: (a) Detection of disease risk, or early-stage disease, with a higher specificity and sensitivity compared to previous testing methods, and (b) "Companion diagnostics" for stratifying patients to receive a treatment choice optimized to their individual disease. This chapter reviews the promise and challenges of business development in this field. Guidelines are provided for the creation of a business model and the generation of a marketing plan around a candidate molecular diagnostic product. Steps to commercialization are outlined using existing molecular diagnostics companies as learning examples.Entities:
Mesh:
Year: 2012 PMID: 22081362 DOI: 10.1007/978-1-60327-216-2_28
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745